CDK5 and pituitary gland adenoma: CDK5 also enhances the migration and invasion of prolactin pituitary adenomas, predominantly by phosphorylation of kinase insert domain receptor (KDR, also known as VEGFR2) at S229 (Table 2) [86] (Fig. 5B).